Relmada Therapeutics
RLMD
#7849
Rank
โ‚น29.27 B
Marketcap
โ‚น399.17
Share price
6.76%
Change (1 day)
900.66%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: โ‚น29.27 Billion

As of December 2025 Relmada Therapeutics has a market cap of โ‚น29.27 Billion. This makes Relmada Therapeutics the world's 7849th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น29.27 B2852.62%
2024โ‚น0.99 B-90.44%
2023โ‚น10.37 B19.34%
2022โ‚น8.69 B-81.31%
2021โ‚น46.51 B21.43%
2020โ‚น38.30 B-4.72%
2019โ‚น40.20 B1579.93%
2018โ‚น2.39 B298.43%
2017โ‚น0.60 B-32.61%
2016โ‚น0.89 B-55.28%
2015โ‚น1.99 B-81.1%
2014โ‚น10.54 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Relmada Therapeutics was reported to be:

โ‚น29.27 Billion
by Nasdaq info icon info icon
โ‚น29.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Taro Pharmaceutical
TARO
โ‚น145.85 B 398.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cytokinetics
CYTK
โ‚น665.98 B 2,175.11%๐Ÿ‡บ๐Ÿ‡ธ USA